Who We work with
We work directly with founders, executive teams, and program leaders navigating commercialization, manufacturing readiness, and operational scale within regulated environments.
Most programs don’t fail because of science — they fail at execution, coordination, and operational readiness. We’re typically engaged when internal teams need experienced operational leadership without adding a full-time executive.
We work with organizations navigating complex development, manufacturing,
and operational transitions.
Typical Clients
Emerging Biotech Companies
Organizations preparing for first-in-human, Phase 1–3, or early commercial readiness that require manufacturing and operational strategy alongside development.
Growing Biotech & Pharma Organizations
Teams scaling programs, adding vendors, or stabilizing operations while managing multiple active initiatives.
CDMOs & Manufacturing Organizations
Organizations improving program execution, onboarding new clients, structuring tech transfers, or aligning operations with customer expectations.
Investors & Operating Partners
VC, PE, and strategic investors seeking independent operational assessment, diligence support, or post-investment program stabilization.
Where We’re Most Valuable
Programs approaching clinical manufacturing for the first time
Tech transfer into a CDMO or new internal facility
Multiple vendors with unclear roles or accountability
Delayed timelines without clear root causes
GMP readiness and documentation gaps
CDMO selection, scope definition, or oversight
Early commercial readiness and operational planning
How Engagements Typically Start
Most engagements begin with a focused 60-minute discussion to understand program stage, key risks, and execution challenges.
If we believe we can provide value, we propose a simple engagement structure — often starting with a short assessment before longer-term support.